Global X China MedTech ETF (02841.HK) has risen more than 7% since the beginning of the year, focusing on China's medical technology industry

NewTimeSpace News: Wind data shows that as of 14:52 on January 8, 2026, Global X China MedTech ETF (02841.HK) rose by 0.63%, with an increase of more than 7% since the beginning of the year.

Global X China MedTech ETF (02841.HK) is an ETF issued by Global X, tracking the Solactive China Medical Technology Index. It covers 30 listed companies from Mainland China and Hong Kong in the fields of medical devices, medical informatization, AI healthcare, etc. (such as WuXi AppTec and United Imaging Healthcare). It invests through physical and synthetic sampling strategies to reflect the growth potential of the medical technology industry.

NewTimeSpace Research suggests that this product is suitable for investors with high risk tolerance, who are long-term optimistic about the upgrading of China's medical technology (such as driven by aging, application of AI technology), and can accept the risks of synthetic strategy derivatives. It is especially suitable as an allocation tool in asset portfolios to capture industry dividends.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.